Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Goldman Sachs Group Inc. has changed its stance on underwriting initial public offerings (IPOs) for companies with all-white ...
announced today the closing of its underwritten initial public offering (the “Offering”) of 2,100,000 Class A Ordinary Shares at a public offering price of $4.00 per share, for total gross ...
More than two-thirds of companies that got listed on the stock market in the last 14 years were subsequently downgraded to ...